EDC4
Basic information
Region (hg38): 16:67873052-67884499
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EDC4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 53 | 53 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 53 | 2 | 2 |
Variants in EDC4
This is a list of pathogenic ClinVar variants found in the EDC4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-67873338-C-G | not specified | Uncertain significance (Mar 31, 2022) | ||
16-67875960-G-T | not specified | Uncertain significance (May 06, 2022) | ||
16-67875965-C-T | not specified | Uncertain significance (May 05, 2023) | ||
16-67875975-G-T | not specified | Uncertain significance (Dec 19, 2023) | ||
16-67875984-A-G | not specified | Uncertain significance (Aug 01, 2024) | ||
16-67875996-A-G | not specified | Uncertain significance (Jul 23, 2024) | ||
16-67876092-A-G | not specified | Uncertain significance (Apr 20, 2023) | ||
16-67876559-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
16-67877354-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
16-67877378-C-T | not specified | Uncertain significance (Jun 13, 2022) | ||
16-67877655-G-A | not specified | Uncertain significance (Aug 01, 2024) | ||
16-67877766-T-A | not specified | Uncertain significance (May 17, 2023) | ||
16-67877774-A-G | Likely benign (Jun 01, 2024) | |||
16-67877792-G-A | not specified | Uncertain significance (Feb 03, 2022) | ||
16-67877798-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
16-67877822-A-G | not specified | Uncertain significance (Jan 26, 2023) | ||
16-67878198-G-A | Benign (Mar 30, 2018) | |||
16-67878223-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
16-67878224-A-G | not specified | Uncertain significance (Nov 28, 2024) | ||
16-67878265-G-A | not specified | Uncertain significance (Jan 05, 2022) | ||
16-67878550-G-A | not specified | Uncertain significance (Sep 09, 2024) | ||
16-67878748-A-G | not specified | Uncertain significance (Sep 08, 2024) | ||
16-67879080-C-T | not specified | Uncertain significance (Aug 19, 2024) | ||
16-67879238-T-G | not specified | Likely benign (Aug 15, 2024) | ||
16-67879319-T-G | Benign (Jun 06, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EDC4 | protein_coding | protein_coding | ENST00000358933 | 29 | 11481 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.106 | 0.894 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.29 | 549 | 813 | 0.676 | 0.0000495 | 9079 |
Missense in Polyphen | 128 | 264.07 | 0.48471 | 3005 | ||
Synonymous | 0.385 | 316 | 325 | 0.973 | 0.0000187 | 2910 |
Loss of Function | 5.93 | 17 | 70.8 | 0.240 | 0.00000390 | 731 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000243 | 0.000242 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000124 | 0.000123 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: In the process of mRNA degradation, seems to play a role in mRNA decapping. Component of a complex containing DCP2 and DCP1A which functions in decapping of ARE-containing mRNAs. Promotes complex formation between DCP1A and DCP2. Enhances the catalytic activity of DCP2 (in vitro). {ECO:0000269|PubMed:16364915}.;
- Pathway
- RNA degradation - Homo sapiens (human);Metabolism of RNA;mRNA decay by 5, to 3, exoribonuclease;Deadenylation-dependent mRNA decay
(Consensus)
Recessive Scores
- pRec
- 0.162
Intolerance Scores
- loftool
- 0.0793
- rvis_EVS
- -1.43
- rvis_percentile_EVS
- 4
Haploinsufficiency Scores
- pHI
- 0.301
- hipred
- Y
- hipred_score
- 0.622
- ghis
- 0.598
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.530
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Edc4
- Phenotype
- immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;
Gene ontology
- Biological process
- biological_process;deadenylation-independent decapping of nuclear-transcribed mRNA;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay
- Cellular component
- P-body;nucleus;nucleoplasm;cytoplasm;cytosol;membrane;cytoplasmic ribonucleoprotein granule
- Molecular function
- protein binding